Johnson & Johnson is a publicly traded company with no controlling owner. Joaquin Duato has served as chairman and CEO since 2022, leading the company through its 2023 split that spun off its consumer health division (now Kenvue, the company behind Tylenol) as a separate entity.
Like most companies of its scale, ownership sits with large institutional index funds rather than any individual or founding family — the Johnson family that gave the company its name has had no controlling role for generations.
Quick Facts
| Company | Johnson & Johnson |
|---|---|
| Ownership Type | Publicly traded (NYSE: JNJ), no controlling owner |
| Chairman & CEO | Joaquin Duato (since 2022) |
| Largest Shareholder | The Vanguard Group (~9.98%) |
| Other Major Shareholders | BlackRock, State Street, Geode Capital Management |
| Founded | 1886, New Brunswick, New Jersey |
Ownership History
| Year | Development |
|---|---|
| 1886 | Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey |
| 1944 | Johnson & Johnson goes public on the NYSE |
| 2022 | Joaquin Duato becomes chairman and CEO, succeeding Alex Gorsky |
| May 2023 | Johnson & Johnson completes the spinoff of its consumer health division as Kenvue, a separately traded public company that includes Tylenol, Band-Aid, and Neutrogena |
| 2023-2026 | Company focuses primarily on pharmaceutical and medical device businesses following the consumer health separation |
Key Ownership Highlights
- The founding Johnson family has held no controlling ownership stake for decades — the company has been broadly held by public shareholders since going public in 1944.
- The 2023 Kenvue spinoff separated the well-known consumer brands (Tylenol, Listerine, Band-Aid) from the pharmaceutical and medical device businesses that now make up the core Johnson & Johnson company.
- Institutional index funds, led by Vanguard, BlackRock, and State Street, collectively hold the largest blocks of shares, typical for a company of J&J’s size and age.
FAQ
Does the Johnson family still own Johnson & Johnson?
No. The company has been publicly traded since 1944, and the founding family has had no controlling ownership stake for decades.
Does Johnson & Johnson still own Tylenol?
No. Tylenol moved to Kenvue, a separate public company, when Johnson & Johnson spun off its consumer health division in May 2023.
